Though rare complications were confirmed, the study supports the net benefit of immunization—particularly for CVD patients.

Through one, two, or three doses of COVID-19 vaccine, people who receive the shots generally see lower risks of overall arterial and venous thrombotic events, according to a study of nearly 46 million people living in England.

The incidence of major events like acute MI, acute ischemic stroke, pulmonary embolism, and deep venous thrombosis was either similar or lower after receipt of one of the three vaccines used during the first 2 years of the pandemic in the United Kingdom compared with before or without the shot.